Subject: Re: Coloplast
If you chose not to take Coloplast to the school dance, you made the right choice. Currently trading at $6.30, this discussion needs to be moved from the non-US stock board to the Falling Knives board. And I definitely will do that because it is no longer trading at the uncomfortable multiples that I mentioned previously. The new CEO has now started and its a credible pick - Gavin Wood from JNJ. They are down on a downward revision of revenue for the year and the write down of goodwill on an acquisition they overpaid for a while back. But I think their forward prospects are quite good and their valuation is no longer demanding.